334 related articles for article (PubMed ID: 9372994)
1. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.
Gheorghiade M; Benatar D; Konstam MA; Stoukides CA; Bonow RO
Am J Cardiol; 1997 Oct; 80(8B):14H-27H. PubMed ID: 9372994
[TBL] [Abstract][Full Text] [Related]
2. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
Ahmed A
J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
[TBL] [Abstract][Full Text] [Related]
3. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
Abraham WT; Wagoner LE
Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
[TBL] [Abstract][Full Text] [Related]
5. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
6. Treatment of systolic and diastolic heart failure in the elderly.
Aronow WS
J Am Med Dir Assoc; 2006 Jan; 7(1):29-36. PubMed ID: 16413432
[TBL] [Abstract][Full Text] [Related]
7. Present and future pharmacotherapy for heart failure.
Doggrell SA; Brown L
Expert Opin Pharmacother; 2002 Jul; 3(7):915-30. PubMed ID: 12083991
[TBL] [Abstract][Full Text] [Related]
8. Treatment of heart failure with preserved systolic function.
de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
[TBL] [Abstract][Full Text] [Related]
9. New treatment strategies in patients with impaired left ventricular systolic function. Part II: Treatment of moderate to severe cardiac dysfunction.
Rozo JC; Barry WL; Stouffer GA
Am J Med Sci; 1999 May; 317(5):312-7. PubMed ID: 10334119
[No Abstract] [Full Text] [Related]
10. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibitors in heart failure: what more do we need to know?
Demers C; Mody A; Teo KK; McKelvie RS
Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.
Shekelle PG; Rich MW; Morton SC; Atkinson CS; Tu W; Maglione M; Rhodes S; Barrett M; Fonarow GC; Greenberg B; Heidenreich PA; Knabel T; Konstam MA; Steimle A; Warner Stevenson L
J Am Coll Cardiol; 2003 May; 41(9):1529-38. PubMed ID: 12742294
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of heart failure due to systolic dysfunction].
Jiménez-Navarro MF; García-Pinilla JM; Montiel Trujillo A; de Teresa Galván E
Rev Esp Cardiol; 2006 Jul; 6 Suppl F():46-52. PubMed ID: 17144976
[TBL] [Abstract][Full Text] [Related]
15. [Therapy for heart failure].
Just H
Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
[TBL] [Abstract][Full Text] [Related]
16. [Practical aspects of diagnosis, treatment and prognosis in chronic heart failure].
Wagdi P
Dtsch Med Wochenschr; 1999 Mar; 124(10):291-5. PubMed ID: 10191824
[No Abstract] [Full Text] [Related]
17. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
[TBL] [Abstract][Full Text] [Related]
18. Sudden death in heart failure patients: effects of optimized medical therapy.
Kao W; Costanzo MR
J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S32-7. PubMed ID: 11016485
[TBL] [Abstract][Full Text] [Related]
19. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
Fox K; Komajda M; Ford I; Robertson M; Böhm M; Borer JS; Steg PG; Tavazzi L; Tendera M; Ferrari R; Swedberg K
Eur Heart J; 2013 Aug; 34(29):2263-70. PubMed ID: 23536611
[TBL] [Abstract][Full Text] [Related]
20. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
